Click for best price
Noninvasive Prenatal Diagnostics Market Size, Share 2024
| Market size in 2023 |
US$ 7957.1 million
|
Forecast Market size by 2030 |
US$ 18770 million
|
| Growth Rate |
CAGR of 13.2% |
Number of Pages |
113 Pages |
The global Noninvasive Prenatal Diagnostics market was valued at US$ 7957.1 million in 2023 and is projected to reach US$ 18770 million by 2030, at a CAGR of 13.2% during the forecast period.
The USA market for Global Noninvasive Prenatal Diagnostics market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Noninvasive Prenatal Diagnostics market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Noninvasive Prenatal Diagnostics market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Noninvasive Prenatal Diagnostics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Noninvasive Prenatal Diagnostics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Noninvasive Prenatal Diagnostics, challenges faced by the industry, and potential opportunities for market players.
The global Noninvasive Prenatal Diagnostics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Noninvasive Prenatal Diagnostics market presents opportunities for various stakeholders, including Hospital, Personal. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Noninvasive Prenatal Diagnostics market. Additionally, the growing consumer demand present avenues for market expansion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Noninvasive Prenatal Diagnostics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Noninvasive Prenatal Diagnostics market.
Market Overview: The report provides a comprehensive overview of the Noninvasive Prenatal Diagnostics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Services, Instrument), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Noninvasive Prenatal Diagnostics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Noninvasive Prenatal Diagnostics market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Noninvasive Prenatal Diagnostics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Noninvasive Prenatal Diagnostics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Noninvasive Prenatal Diagnostics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Noninvasive Prenatal Diagnostics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Noninvasive Prenatal Diagnostics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Noninvasive Prenatal Diagnostics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Noninvasive Prenatal Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Market segment by Application
Global Noninvasive Prenatal Diagnostics Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Natera
- Illumina
- BGI Diagnosis
- Ariosa Diagnostics
- Quest Diagnostics
- Premaitha Health
- NIPD Genetics
- Labcorp
- Ravgen
- LifeCodexx
- TrovaGene
- Berry Genomics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Noninvasive Prenatal Diagnostics, market overview.
Chapter 2: Global Noninvasive Prenatal Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Noninvasive Prenatal Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Noninvasive Prenatal Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Noninvasive Prenatal Diagnostics Market, Global Outlook and Forecast 2024-2030 |
| Market size in 2023 |
US$ 7957.1 million
|
| Forecast Market size by 2030 |
US$ 18770 million
|
| Growth Rate |
CAGR of 13.2% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
113 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Noninvasive Prenatal Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Noninvasive Prenatal Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Noninvasive Prenatal Diagnostics Overall Market Size
2.1 Global Noninvasive Prenatal Diagnostics Market Size: 2023 VS 2030
2.2 Global Noninvasive Prenatal Diagnostics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Noninvasive Prenatal Diagnostics Players in Global Market
3.2 Top Global Noninvasive Prenatal Diagnostics Companies Ranked by Revenue
3.3 Global Noninvasive Prenatal Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Noninvasive Prenatal Diagnostics Companies in Global Market, by Revenue in 2023
3.5 Global Companies Noninvasive Prenatal Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Noninvasive Prenatal Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Noninvasive Prenatal Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Noninvasive Prenatal Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Noninvasive Prenatal Diagnostics Market Size Markets, 2023 & 2030
4.1.2 Services
4.1.3 Instrument
4.2 By Type - Global Noninvasive Prenatal Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Noninvasive Prenatal Diagnostics Revenue, 2019-2024
4.2.2 By Type - Global Noninvasive Prenatal Diagnostics Revenue, 2025-2030
4.2.3 By Type - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Noninvasive Prenatal Diagnostics Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Personal
5.1.4 Other
5.2 By Application - Global Noninvasive Prenatal Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Noninvasive Prenatal Diagnostics Revenue, 2019-2024
5.2.2 By Application - Global Noninvasive Prenatal Diagnostics Revenue, 2025-2030
5.2.3 By Application - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Noninvasive Prenatal Diagnostics Market Size, 2023 & 2030
6.2 By Region - Global Noninvasive Prenatal Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Noninvasive Prenatal Diagnostics Revenue, 2019-2024
6.2.2 By Region - Global Noninvasive Prenatal Diagnostics Revenue, 2025-2030
6.2.3 By Region - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Noninvasive Prenatal Diagnostics Revenue, 2019-2030
6.3.2 US Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.3.3 Canada Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.3.4 Mexico Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Noninvasive Prenatal Diagnostics Revenue, 2019-2030
6.4.2 Germany Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.4.3 France Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.4.4 U.K. Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.4.5 Italy Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.4.6 Russia Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.4.7 Nordic Countries Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.4.8 Benelux Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Noninvasive Prenatal Diagnostics Revenue, 2019-2030
6.5.2 China Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.5.3 Japan Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.5.4 South Korea Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.5.5 Southeast Asia Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.5.6 India Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Noninvasive Prenatal Diagnostics Revenue, 2019-2030
6.6.2 Brazil Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.6.3 Argentina Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue, 2019-2030
6.7.2 Turkey Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.7.3 Israel Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.7.4 Saudi Arabia Noninvasive Prenatal Diagnostics Market Size, 2019-2030
6.7.5 UAE Noninvasive Prenatal Diagnostics Market Size, 2019-2030
7 Noninvasive Prenatal Diagnostics Companies Profiles
7.1 Natera
7.1.1 Natera Company Summary
7.1.2 Natera Business Overview
7.1.3 Natera Noninvasive Prenatal Diagnostics Major Product Offerings
7.1.4 Natera Noninvasive Prenatal Diagnostics Revenue in Global Market (2019-2024)
7.1.5 Natera Key News & Latest Developments
7.2 Illumina
7.2.1 Illumina Company Summary
7.2.2 Illumina Business Overview
7.2.3 Illumina Noninvasive Prenatal Diagnostics Major Product Offerings
7.2.4 Illumina Noninvasive Prenatal Diagnostics Revenue in Global Market (2019-2024)
7.2.5 Illumina Key News & Latest Developments
7.3 BGI Diagnosis
7.3.1 BGI Diagnosis Company Summary
7.3.2 BGI Diagnosis Business Overview
7.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Major Product Offerings
7.3.4 BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue in Global Market (2019-2024)
7.3.5 BGI Diagnosis Key News & Latest Developments
7.4 Ariosa Diagnostics
7.4.1 Ariosa Diagnostics Company Summary
7.4.2 Ariosa Diagnostics Business Overview
7.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Major Product Offerings
7.4.4 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue in Global Market (2019-2024)
7.4.5 Ariosa Diagnostics Key News & Latest Developments
7.5 Quest Diagnostics
7.5.1 Quest Diagnostics Company Summary
7.5.2 Quest Diagnostics Business Overview
7.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Major Product Offerings
7.5.4 Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue in Global Market (2019-2024)
7.5.5 Quest Diagnostics Key News & Latest Developments
7.6 Premaitha Health
7.6.1 Premaitha Health Company Summary
7.6.2 Premaitha Health Business Overview
7.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Major Product Offerings
7.6.4 Premaitha Health Noninvasive Prenatal Diagnostics Revenue in Global Market (2019-2024)
7.6.5 Premaitha Health Key News & Latest Developments
7.7 NIPD Genetics
7.7.1 NIPD Genetics Company Summary
7.7.2 NIPD Genetics Business Overview
7.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Major Product Offerings
7.7.4 NIPD Genetics Noninvasive Prenatal Diagnostics Revenue in Global Market (2019-2024)
7.7.5 NIPD Genetics Key News & Latest Developments
7.8 Labcorp
7.8.1 Labcorp Company Summary
7.8.2 Labcorp Business Overview
7.8.3 Labcorp Noninvasive Prenatal Diagnostics Major Product Offerings
7.8.4 Labcorp Noninvasive Prenatal Diagnostics Revenue in Global Market (2019-2024)
7.8.5 Labcorp Key News & Latest Developments
7.9 Ravgen
7.9.1 Ravgen Company Summary
7.9.2 Ravgen Business Overview
7.9.3 Ravgen Noninvasive Prenatal Diagnostics Major Product Offerings
7.9.4 Ravgen Noninvasive Prenatal Diagnostics Revenue in Global Market (2019-2024)
7.9.5 Ravgen Key News & Latest Developments
7.10 LifeCodexx
7.10.1 LifeCodexx Company Summary
7.10.2 LifeCodexx Business Overview
7.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Major Product Offerings
7.10.4 LifeCodexx Noninvasive Prenatal Diagnostics Revenue in Global Market (2019-2024)
7.10.5 LifeCodexx Key News & Latest Developments
7.11 TrovaGene
7.11.1 TrovaGene Company Summary
7.11.2 TrovaGene Business Overview
7.11.3 TrovaGene Noninvasive Prenatal Diagnostics Major Product Offerings
7.11.4 TrovaGene Noninvasive Prenatal Diagnostics Revenue in Global Market (2019-2024)
7.11.5 TrovaGene Key News & Latest Developments
7.12 Berry Genomics
7.12.1 Berry Genomics Company Summary
7.12.2 Berry Genomics Business Overview
7.12.3 Berry Genomics Noninvasive Prenatal Diagnostics Major Product Offerings
7.12.4 Berry Genomics Noninvasive Prenatal Diagnostics Revenue in Global Market (2019-2024)
7.12.5 Berry Genomics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Noninvasive Prenatal Diagnostics Market Opportunities & Trends in Global Market
Table 2. Noninvasive Prenatal Diagnostics Market Drivers in Global Market
Table 3. Noninvasive Prenatal Diagnostics Market Restraints in Global Market
Table 4. Key Players of Noninvasive Prenatal Diagnostics in Global Market
Table 5. Top Noninvasive Prenatal Diagnostics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Noninvasive Prenatal Diagnostics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Noninvasive Prenatal Diagnostics Revenue Share by Companies, 2019-2024
Table 8. Global Companies Noninvasive Prenatal Diagnostics Product Type
Table 9. List of Global Tier 1 Noninvasive Prenatal Diagnostics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Noninvasive Prenatal Diagnostics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Noninvasive Prenatal Diagnostics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Noninvasive Prenatal Diagnostics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Noninvasive Prenatal Diagnostics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Noninvasive Prenatal Diagnostics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Noninvasive Prenatal Diagnostics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Noninvasive Prenatal Diagnostics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2025-2030
Table 30. Natera Company Summary
Table 31. Natera Noninvasive Prenatal Diagnostics Product Offerings
Table 32. Natera Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 33. Natera Key News & Latest Developments
Table 34. Illumina Company Summary
Table 35. Illumina Noninvasive Prenatal Diagnostics Product Offerings
Table 36. Illumina Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 37. Illumina Key News & Latest Developments
Table 38. BGI Diagnosis Company Summary
Table 39. BGI Diagnosis Noninvasive Prenatal Diagnostics Product Offerings
Table 40. BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 41. BGI Diagnosis Key News & Latest Developments
Table 42. Ariosa Diagnostics Company Summary
Table 43. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Product Offerings
Table 44. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 45. Ariosa Diagnostics Key News & Latest Developments
Table 46. Quest Diagnostics Company Summary
Table 47. Quest Diagnostics Noninvasive Prenatal Diagnostics Product Offerings
Table 48. Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 49. Quest Diagnostics Key News & Latest Developments
Table 50. Premaitha Health Company Summary
Table 51. Premaitha Health Noninvasive Prenatal Diagnostics Product Offerings
Table 52. Premaitha Health Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 53. Premaitha Health Key News & Latest Developments
Table 54. NIPD Genetics Company Summary
Table 55. NIPD Genetics Noninvasive Prenatal Diagnostics Product Offerings
Table 56. NIPD Genetics Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 57. NIPD Genetics Key News & Latest Developments
Table 58. Labcorp Company Summary
Table 59. Labcorp Noninvasive Prenatal Diagnostics Product Offerings
Table 60. Labcorp Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 61. Labcorp Key News & Latest Developments
Table 62. Ravgen Company Summary
Table 63. Ravgen Noninvasive Prenatal Diagnostics Product Offerings
Table 64. Ravgen Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 65. Ravgen Key News & Latest Developments
Table 66. LifeCodexx Company Summary
Table 67. LifeCodexx Noninvasive Prenatal Diagnostics Product Offerings
Table 68. LifeCodexx Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 69. LifeCodexx Key News & Latest Developments
Table 70. TrovaGene Company Summary
Table 71. TrovaGene Noninvasive Prenatal Diagnostics Product Offerings
Table 72. TrovaGene Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 73. TrovaGene Key News & Latest Developments
Table 74. Berry Genomics Company Summary
Table 75. Berry Genomics Noninvasive Prenatal Diagnostics Product Offerings
Table 76. Berry Genomics Noninvasive Prenatal Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 77. Berry Genomics Key News & Latest Developments
List of Figures
Figure 1. Noninvasive Prenatal Diagnostics Segment by Type in 2023
Figure 2. Noninvasive Prenatal Diagnostics Segment by Application in 2023
Figure 3. Global Noninvasive Prenatal Diagnostics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Noninvasive Prenatal Diagnostics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Noninvasive Prenatal Diagnostics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Noninvasive Prenatal Diagnostics Revenue in 2023
Figure 8. By Type - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
Figure 9. By Application - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
Figure 10. By Type - Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
Figure 12. By Application - Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
Figure 14. By Region - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
Figure 15. By Country - North America Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
Figure 16. US Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
Figure 20. Germany Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 21. France Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
Figure 28. China Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 32. India Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
Figure 34. Brazil Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue Market Share, 2019-2030
Figure 37. Turkey Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 41. Natera Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. Illumina Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Premaitha Health Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. NIPD Genetics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Labcorp Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Ravgen Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. LifeCodexx Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. TrovaGene Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Berry Genomics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
